Jacobson Pharma Corp. Ltd. engages in the development, production, marketing, and sale of generic drugs. The firm operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.
02633.HK stock price ended at $1.28 on 星期五, after rising 0.00%
On the latest trading day Jan 16, 2026, the stock price of 02633.HK rose by 0.00%, climbing from $1.27 to $1.28. Throughout the session, the stock experienced a volatility of 0.79%, with prices fluctuating between a daily low of $1.27 and a high of $1.28. Alongside this price increase, trading volume also rose by 254.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 154.0K shares were traded, amounting to a market value of approximately $2.5B.